R&D | April 15, 2026
Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
The license is valid for five years, effective from April 9, 2026
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The leading hospital chain appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
Subscribe To Our Newsletter & Stay Updated
